29.1 C
Delhi
Wednesday, September 17, 2025

US FDA approves updated COVID-19 vaccines against currently circulating variants

Date:

Share post:

Donate-GC-Razorpay

Los Angeles: The US Food and Drug Administration (FDA) approved and granted emergency use authorisation for updated mRNA COVID-19 vaccines to better protect against currently circulating variants.

The FDA said on Thursday that the updated vaccines will target the Omicron variant KP.2 strain.

“Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

“The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, both of which are authorised for emergency use for individuals 6 months through 11 years of age,” the FDA said in a press release.

Related articles

The American Military in Bangladesh: Quiet Landings, Loud Questions

The quiet arrival of American boots on Bangladeshi soil has raised eyebrows not just in Dhaka but in...

Qatar’s Blood Money: How Doha Bankrolled Hamas and Fueled the October 7 Massacre

 Since 2012, Qatar has positioned itself as Gaza’s saviour while quietly acting as its executioner. The numbers are...

Goa Is Not Falling, Goa Is Rising Differently – Go Goa 365 Days

Don’t fall for the negative stories about falling numbers of Goan tourists even though my good friend Tehseen...

TDB backs India’s first 240V electric motorcycle platform

New Delhi: Aligning with the government’s Aatmanirbhar Bharat mission, the Technology Development Board (TDB) under the Department of...